Primevax, Llc
Get Full AccessDescription
- PrimeVax Immuno-Oncology, Inc. is developing the only one-time one-week cancer treatment. We use a combination of the dengue fever virus and autologous dendritic cells to induce a strong immune response along with personalized tumor targeting. We intend to run our first phase 1 human clinical trial in 2017.
-
Headquarters:400 Cypress Avenue , South San Francisco, California, United States
More -
Phone Number: +1 503-490-6066
-
Website: https://www.primevax.com
-
Employees:8
-
Revenue:$1 - 10M
-
Legal Name:Primevax, Llc
-
Primevax, Llc's Social Media
-
Is this data correct?
-
| NAICS Code: 621111 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Primevax, Llc
-
Where are Primevax, Llc's Headquarters?
Primevax, Llc's Headquarters are in 400 Cypress Avenue ,South San Francisco,California,United States
-
What is Primevax, Llc's phone number?
Primevax, Llc's phone number is +1 503-490-6066
-
What is Primevax, Llc's official website?
Primevax, Llc's official website is https://www.primevax.com
-
What is Primevax, Llc's Revenue?
Primevax, Llc's revenue is $1 - 10M
-
What is Primevax, Llc's NAICS code?
Primevax, Llc's NAICS code is 621111
-
How many employees are working in Primevax, Llc
Primevax, Llc has 8 employees
-
What is Primevax, Llc's Industry?
Primevax, Llc is in the industry of Pharmaceuticals
-
Who is Primevax, Llc's Chief Technology Officer?
Primevax, Llc's Chief Technology Officer is Bruce Lyday